Characterization of biotransformation enzyme activities in primary rat proximal tubular cells

G J Schaaf1, E M de Groene, R F Maas

  • 1Department of Veterinary Pharmacology, Pharmacy and Toxicology (VFFT), Faculty of Veterinary Medicine, Utrecht University, PO Box 80152 NL 3508 TD, Utrecht, The Netherlands. g.schaaf@vfft.vet.uu.nl

Insights

Primary cultured rat proximal tubular cells show rapid loss of Phase I (cytochrome P450) enzyme activity within 24 hours, while Phase II enzymes remain stable for a week, limiting their in vitro toxicity study applications.

Area of Science:

  • Toxicology
  • Cell Biology
  • Biochemistry

Background:

  • The proximal tubule is a key site for xenobiotic metabolism and toxicity.
  • Primary cultured proximal tubular (PT) cells are valuable in vitro models for studying drug metabolism and toxicity.
  • Understanding the stability of biotransformation enzymes in cultured PT cells is crucial for interpreting experimental results.

Purpose of the Study:

  • To characterize the activity and expression of Phase I (cytochrome P450) and Phase II biotransformation enzymes in primary cultured rat PT cells over time.
  • To assess the stability of these enzyme activities during the initial culture period.

Main Methods:

  • Primary rat PT cells were cultured.
  • Cytochrome P450 (CYP450) enzyme activities were measured using specific marker substrates (e.g., 7-ethoxyresorufin, caffeine, testosterone).
  • Expression of CYP450 apoproteins was analyzed by immunoblotting.
  • Phase II enzyme activities (GST, GGT, beta-lyase, UGT) were determined using specific substrates.

Main Results:

  • CYP450 enzyme activities significantly decreased within 24 hours of culture, with substantial loss observed.
  • Expression of several CYP450 apoproteins (CYP1A, CYP2C, CYP2D, CYP2E, CYP4A) was detected in freshly isolated cells but not consistently throughout culture.
  • Phase II enzyme activities remained relatively stable throughout one week of culture, showing greater resilience than Phase I enzymes.

Conclusions:

  • Primary cultured PT cells exhibit a time-dependent decline in Phase I biotransformation enzyme activity, particularly within the first 24 hours.
  • Phase II enzyme activities are more stable in cultured PT cells over a one-week period.
  • The significant loss of Phase I activity over time presents a limitation for using these cells in long-term in vitro studies of biotransformation-mediated toxicity.

Related Concept Videos

Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...